Canada markets open in 4 hours 23 minutes

Agios Pharmaceuticals, Inc. (8AP.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
44.80+1.40 (+3.23%)
As of 08:03AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
29,403
26,823
14,240
0
0
-
Cost of Revenue
2,954
2,881
1,704
0
2,805
-
Gross Profit
26,449
23,942
12,536
0
200,391
-
Operating Expenses
Research Development
296,845
295,526
279,910
256,973
220,811
-
Selling General and Administrative
122,550
119,903
121,673
121,445
115,105
-
Total Operating Expenses
419,395
415,429
401,583
378,418
335,916
-
Operating Income or Loss
-392,946
-391,487
-389,047
-378,418
-335,916
-
Interest Expense
-
-
-
-
17,832
0
Total Other Income/Expenses Net
6,185
6,055
144,453
21,072
-
-
Income Before Tax
-352,619
-352,088
-231,801
-356,510
-329,305
-
Income from Continuing Operations
-352,619
-352,088
-231,801
-356,510
-329,305
-
Net Income
-352,619
-352,088
-231,801
1,604,715
-327,370
-
Net Income available to common shareholders
-352,619
-352,088
-231,801
1,604,715
-327,370
-
Basic EPS
26.55
-6.33
-4.23
26.55
-4.74
-
Diluted EPS
26.55
-6.33
-4.23
26.55
-4.74
-
Basic Average Shares
60,447
55,651
54,789
60,447
68,998
-
Diluted Average Shares
60,447
55,651
54,789
60,447
68,998
-